[Depth] Market Forecast Report of the Three Hot Spots of Precision Medicine

In many subdivisions of precision medicine in China, the medical theories of “ gene sequencing , stem cell, and cellular immunotherapy” are relatively mature, and it is most likely to take the lead in entering the stage of large-scale commercialization in the future. This paper analyzes and predicts the scale of the three major markets of precision medicine , "gene sequencing, stem cell, and cellular immunotherapy." The data published in this paper is the exclusive prediction result of the China Investment Consulting Industry Research Center.

Gene sequencing - the global gene sequencing market will reach $16 billion in 2020

Gene sequencing is an innovative technology for medical diagnosis and treatment, and an entry point for precision medicine. From the fertility detection of tens of billions of space, to the individualized treatment of cancer in the 100 billion market, to the trillion-dollar genetic examination and consultation market, there is a huge application prospect.

The breakthrough in genetic testing technology is the main factor driving the growth of the market. On the one hand, genetic testing technology is constantly upgrading, and it is applied in more and more fields. The accuracy of genetic testing is also increasing year by year. On the other hand, with the continuous popularization of sequencing technology and the maturity of application, the cost of gene sequencing is decreasing year by year. The decline in sequencing costs will drive the further popularization of gene sequencing services.

In the past five years, the global gene sequencing market has grown at a rate of 20%. The China Investment Consulting Industry Research Center predicts that the cost of global gene sequencing will decline further in the future, but the scale of services will increase significantly over the past five years. The speed will remain at around 18%, and by 2020 the global gene sequencing market will reach $16 billion.

Although China is not the region with the highest proportion of cancer in the world, due to its large population base, China added 3.07 million (21.9% of the world) cancer in 2012 and caused 2.2 million (26.8% of the world) deaths. According to the 2014 China Statistical Yearbook, the diseases with the highest mortality rates in China are malignant, cardiovascular and respiratory diseases. China is a country with high cancer incidence. Compared with reproductive health, individualized treatment of tumors has a larger market for genetic testing.

China's genetic industry policy environment has changed, while industry supervision has become stricter, the government's encouraging attitude has gradually become clear. Before 2014, China's genetic industry was basically in a state of laissez-faire development. Since February 2014, the country has stopped genetic testing projects, and the genetic industry has truly been included in the regulatory vision. From June to the end of 2014, entering the partial release period, the gene sequencing industry is now in the policy encouragement development period, and the clear policy attitude is of great significance to the development of the gene sequencing industry.

When the cost of human genome sequencing has been greatly reduced and the development of big data has made complex analysis possible, personalized medicine will achieve rapid development. Now the cost of human genome sequencing has dropped below $1,000, and this number will continue in the future. decline. This is the most obvious performance in non-invasive prenatal screening, from the initial listing of 3000-4000 yuan to the current 1000-1500 yuan each time.

In the development and application of genetic technology, China and developed countries are at the same starting line. CIC Consulting Industry Research Center predicts that in the future, China will realize that the importance of genetic testing will reach 15%-20% of the total population in the next five years. The potential demand of about 300 million people will be at least 3 million person-times per year. Above, the cost of genetic testing in the future is expected to enter the “hundred yuan era”, with an average of about 800 yuan per test, and the market size of gene sequencing services can reach 2.4 billion yuan.

Centrifuge Tube

Centrifugal tubes are generally disposable experimental devices and are not recommended for repeated use. In order to save money, PP centrifugal tube can be reused according to the situation, but it needs to be thoroughly disinfected by high temperature and high pressure to ensure the scientific results of the experiment. PE material centrifugal tube, can not be high temperature and high pressure disinfection.

We all know that in plastic centrifugal tubes, commonly used materials are polyethylene (PE), polycarbonate (PC), polypropylene (PP) and so on. The performance of polypropylene PP tube will be relatively good. Therefore, we should consider the plastic centrifugal tube of polypropylene as far as possible when selecting plastic centrifugal tube.

Use method of centrifugal tube:
1. Because the graduated centrifugal tube is a metering device, it must be cleaned and dried before use.
2. When reading, be sure to observe the bending liquid level correctly, otherwise it will introduce a certain error.
3. When used, the number of centrifugal tubes should be determined according to the model of the centrifuge. For example, if a centrifuge with two tubes is used for a single test, the same volume of liquid must be loaded into the other centrifugal tube to maintain balance.
4. The centrifuge tube and the centrifuge casing should be compatible. Pipe should not be too long, otherwise it is easy to break when rotating. But it is not easy to be too short, too short pipe is unstable when rotating in the air, and easy to cause breakage. Too thick sleeve not into, too thin rotation instability, round mouth should be greater than the inner diameter of the casing.
5. After the centrifugal tube is placed into the casing of the centrifuge for stratified separation, it should be stopped naturally when it stops rotating, and it should never be forced to stop by external force.

Precautions for centrifugal tube:
When we use centrifugal tube, do not use a tube many times, pay attention to the sample volatilization and some radioactive or corrosive sample leakage; In the storage process, it is necessary to seal well; It is necessary to prevent the deformation of centrifugal tube in the process of use.

Lab Consumables Plastic Centrifuge Tube,50Ml Centrifuge Tube,15Ml Centrifuge Tube,2Ml Centrifuge Tube

Changchun ZYF science and technology CO.,LTD , https://www.zyf-medical.com